Pure Global

Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 125220. The device is manufactured by Seegene Inc. from South Korea, classified as In Vitro Diagnostic Device. The authorized representative in the UK is MT Promedt Consulting Ltd.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 125220โ€ขRef: 125220

Device Type

In Vitro Diagnostic Device

Devices

Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Nov 12, 2024

Manufacturer Information

Address

Taewon Bldg., 91, Ogeum-ro, Songpa-gu

Seoul, South Korea

Created Date

Aug 5, 2021

Authorized Representative

Relationship Type

UK Responsible Person

Address

Beaver House, 23-38 Hythe Bridge Street

Oxford, England, United Kingdom

Postcode: OX1 2EP

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing